In vitro phase I metabolism of vinclozolin by human liver microsomes

References

• Bourrie M, Meunier V, Berger Y, Fabre G. (1996). Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J Pharmacol Exp Ther 277:321–32.
   PubMed Web of Science ®Google Scholar
• Bursztyka J, Debrauwer L, Perdu E, et al. (2008). Biotransformation of vinclozolin in rat precision-cut liver slices: comparison with in vivo metabolic pattern. J Agric Food Chem 56:4832–9.
   PubMed Web of Science ®Google Scholar
• Cruz-Hurtado M, López-González ML, Escobar-Wilches DC, et al. (2018). Analysis of 3',5'-dichloro-2,3,4-trihydroxy-2-methylbutylanilide (DTMBA) as a new potential biomarker of exposure to vinclozolin in urine. Toxicol Appl Pharmacol 346:1–8.
   PubMed Web of Science ®Google Scholar
• Galli CL, Sensi C, Fumagalli A, et al. (2014). A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites. PLoS One 9:e104822.
   PubMed Web of Science ®Google Scholar
• Gray LE Jr., Ostby JS, Kelce, WR (1994). Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicol Appl Pharmacol 129:46–52.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang XL, Zhang JW, Wu KS. (2015). Impact of endocrine-disrupting chemicals on reproductive function in zebrafish (Danio rerio). Reprod Domest Anim 50:1–6.
   PubMed Web of Science ®Google Scholar
• Kavlock R, Cummings A. (2005). Mode of action: inhibition of androgen receptor function–vinclozolin-induced malformations in reproductive development. Crit Rev Toxicol 35:721–6.
   PubMed Web of Science ®Google Scholar
• Kelce WR, Lambright CR, Gray LE, Jr., Roberts KP. (1997). Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. Toxicol Appl Pharmacol 142:192–200.
   PubMed Web of Science ®Google Scholar
• Kelce WR, Monosson E, Gamcsik, MP, et al. (1994). Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 126:276–85.
   PubMed Web of Science ®Google Scholar
• Khojasteh SC, Prabhu S, Kenny JR, et al. (2011). Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet 36:1–16.
   PubMed Web of Science ®Google Scholar
• Kinonen T, Pasanen M, Gynther J, et al. (1995). Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6. Br J Pharmacol 116:2625–30.
   PubMed Web of Science ®Google Scholar
• Komatsu T, Yamazaki H, Asahi S, et al. (2000). Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Drug Metab Dispos 28:1361–8.
   PubMed Web of Science ®Google Scholar
• Kutting B, Goen T, Schwegler U, et al. (2009). Monoarylamines in the general population–a cross-sectional population-based study including 1004 Bavarian subjects. Int J Hyg Environ Health 212:298–309.
   PubMed Web of Science ®Google Scholar
• Lindh CH, Littorin M, Amilon A, Jonsson BA. (2007). Analysis of 3,5-dichloroaniline as a biomarker of vinclozolin and iprodione in human urine using liquid chromatography/triple quadrupole mass spectrometry. Rapid Commun Mass Spectrom 21:536–42.
   PubMed Web of Science ®Google Scholar
• McKillop D, Wild MJ, Butters CJ, Simcock C. (1998). Effects of propofol on human hepatic microsomal cytochrome P450 activities. Xenobiotica 28:845–53.
   PubMed Web of Science ®Google Scholar
• Molina-Molina JM, Hillenweck A, Jouanin I, et al. (2006). Steroid receptor profiling of vinclozolin and its primary metabolites. Toxicol Appl Pharmacol 216:44–54.
   PubMed Web of Science ®Google Scholar
• Monosson E, Kelce, WR, Lambright, C, et al. (1999). Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat. Toxicol Ind Health 15:65–79.
   PubMed Web of Science ®Google Scholar
• Moorman WJ, Cheever KL, Skaggs SR, et al. (2000). Male adolescent exposure to endocrine-disrupting pesticides: vinclozolin exposure in peripubertal rabbits. Andrologia 32:285–93.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Takanobu H, Tamura I, et al. (2014). Verification of responses of Japanese medaka (Oryzias latipes) to anti-androgens, vinclozolin and flutamide, in short-term assays. J Appl Toxicol 34:545–53.
   PubMed Web of Science ®Google Scholar
• Obach RS, 1999. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metabol Disp 27:1350–59.
   PubMed Web of Science ®Google Scholar
• Ono S, Hatanaka T, Hotta H, et al. (1996). Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26:681–93.
   PubMed Web of Science ®Google Scholar
• Rane A, Wilkinson GR, Shand DG. (1977). Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. J Pharmacol Exp Therap 200:420–4.
   PubMed Web of Science ®Google Scholar
• Rathahao-Paris E, Paris A, Bursztyka, et al. (2014). Identification of xenobiotic metabolites from biological fluids using flow injection analysis high-resolution mass spectrometry and post-acquisition data filtering. Rapid Commun Mass Spectrom 28:2713–22.
   PubMed Web of Science ®Google Scholar
• Sierra-Santoyo A, Angeles-Soto E, de Lourdes Lopez-Gonzalez M, et al. (2012). In vitro metabolism of the anti-androgenic fungicide vinclozolin by rat liver microsomes. Arch Toxicol 86:413–21.
   PubMed Web of Science ®Google Scholar
• Sierra-Santoyo A, Barton HA, Hughes MF. (2004). Liquid chromatography determination of the anti-androgen vinclozolin and its metabolites in rat serum. J Chromatogr B Analyt Technol Biomed Life Sci 809:105–10.
   PubMed Web of Science ®Google Scholar
• Sierra-Santoyo A, Castaneda-Hernandez G, Harrison RA, et al. (2008). Pharmacokinetics and dosimetry of the antiandrogen vinclozolin after oral administration in the rat. Toxicol Sci 106:55–63.
   PubMed Web of Science ®Google Scholar
• Sjögren E, Lennernäs H, Andersson TB, et al. (2009). The multiple depletion curves method provides accurate estimates of intrinsic clearance (CLint), maximum velocity of the metabolic reaction (Vmax), and Michaelis constant (Km): accuracy and robustness evaluated through experimental data and Monte Carlo simulations. Drug Metabol Disp 37:47–58.
   PubMed Web of Science ®Google Scholar
• Stresser DM, Broudy MI, Ho T, et al. (2004). Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible. Drug Metab Dispos 32:105–12.
   PubMed Web of Science ®Google Scholar
• Szeto SY, Burlinson NE, Rahe JE, Oloffs PC. (1989). Kinetics of hydrolysis of the dicarboximide fungicide vinclozolin. J Agricul Food Chem 37:523–9.
   Web of Science ®Google Scholar
• Turci R, Barisano A, Balducci C, et al. (2006). Determination of dichloroanilines in human urine by gas chromatography/mass spectrometry: validation protocol and establishment of Reference Values in a population group living in central Italy. Rapid Commun Mass Spectrom 20:2621–5.
   PubMed Web of Science ®Google Scholar
• US EPA, R-P. (2000). R.E.D. FACTS Vinclozolin 2013:3–8.
   Google Scholar
• Veeramachaneni DN, Palmer JS, Amann RP, et al. (2006). Disruption of sexual function, FSH secretion, and spermiogenesis in rabbits following developmental exposure to vinclozolin, a fungicide. Reproduction 131:805–16.
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K, Von Moltke LL, Greenblatt DJ. (2001). Human drug metabolism and the cytochromes P450: application and relevance of in vitro models. J Clin Pharmacol 41:1149–79.
   PubMed Web of Science ®Google Scholar
• Weiss T, Angerer J. (2002). Simultaneous determination of various aromatic amines and metabolites of aromatic nitro compounds in urine for low level exposure using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 778:179–92.
   PubMed Web of Science ®Google Scholar
• Wickerham EL, Lozoff B, Shao J, et al. (2012). Reduced birth weight in relation to pesticide mixtures detected in cord blood of full-term infants. Environ Int 47:80–5.
   PubMed Web of Science ®Google Scholar
• Wittke K, Hajimiragha H, Dunemann L, Begerow J. (2001). Determination of dichloroanilines in human urine by GC-MS, GC-MS-MS, and GC-ECD as markers of low-level pesticide exposure. J Chromatogr B Biomed Sci Appl 755:215–28.
   PubMed Web of Science ®Google Scholar
• Wolf CJ, LeBlanc GA, Ostby JS, Gray LE Jr. (2000). Characterization of the period of sensitivity of fetal male sexual development to vinclozolin. Toxicol Sci 55:152–61.
   PubMed Web of Science ®Google Scholar
• Wong C, Kelce WR, Sar M, Wilson EM. (1995). Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J Biol Chem 270:19998–20003.
   PubMed Web of Science ®Google Scholar
• Wu B. (2011). Substrate inhibition kinetics in drug metabolism reactions. Drug Metab Rev 43:440–56.
   PubMed Web of Science ®Google Scholar
• Zober A, Hoffmann G, Ott MG, et al. (1995). Study of morbidity of personnel with potential exposure to vinclozolin. Occup Environ Med 52:233–41.
   PubMed Web of Science ®Google Scholar